Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-6,479
Closed -$266K 15
2018
Q4
$266K Sell
6,479
-5,259
-45% -$216K 2.36% 22
2018
Q3
$481K Sell
11,738
-5,624
-32% -$227K 1.07% 27
2018
Q2
$690K Sell
17,362
-1,641
-9% -$63.1K 0.85% 32
2018
Q1
$710K Sell
19,003
-1,435
-7% -$58K 0.33% 91
2017
Q4
$874K Sell
20,438
-1,345
-6% -$53.6K 0.25% 114
2017
Q3
$799K Sell
21,783
-1,822
-8% -$73.5K 0.16% 169
2017
Q2
$1.07M Buy
23,605
+4,352
+23% +$192K 0.17% 173
2017
Q1
$819K Buy
19,253
+6,762
+54% +$276K 0.11% 227
2016
Q4
$501K Buy
12,491
+6,318
+102% +$244K 0.07% 278
2016
Q3
$240K Buy
+6,173
New +$233K 0.03% 402

Other funds holding HOLX

Nuveen Fund Advisors's HOLX Position: Q1 2019 in Review

Nuveen Fund Advisors sold out of Hologic (HOLX) in Q1 2019, closing a stake of 6,479 shares — an estimated $266K sold.

Nuveen Fund Advisors first reported a position in HOLX in Q3 2016 and held it in 10 quarters. The position peaked at $1.07M in Q2 2017. 466 funds tracked by Wall St. Rank hold HOLX as of Q1 2019.

  • Nuveen Fund Advisors reported no remaining Hologic position as of Q1 2019 after selling out during the quarter.
  • Nuveen Fund Advisors sold 6,479 Hologic shares in Q1 2019, an estimated $266K.
  • Nuveen Fund Advisors first reported a position in Hologic in Q3 2016 and held it in 10 quarters.
  • Nuveen Fund Advisors's Hologic position peaked at $1.07M in Q2 2017.
  • 466 funds tracked by Wall St. Rank held Hologic as of Q1 2019.

Based on Nuveen Fund Advisors's 13F filing for Q1 2019, filed 14 May 2019.